Comment from LoGiudice, Suzanne

I support the action to revoke the licenses for the Comirnaty and Spikevax COVID vaccines for all demographic groups. From what I’ve researched, the manufacturers did not fully meet the requirements normally expected for a Biologics License Application through the FDA process. Beyond the licensing questions, many Americans have growing concerns about the broader impact these vaccines have had on public health and personal freedom over the past few years. Historically, when safety signals appeared with vaccines, action was taken quickly. For example, in 1976 the swine flu vaccine campaign in the U.S. was stopped after an estimated 32 deaths were linked to the vaccine. By comparison, from December 2020 through November 28, 2025, there have been 1,671,991 adverse events reported to the Vaccine Adverse Events Reporting System (VAERS) related to COVID-19 vaccines, including 38,913 reported deaths. Despite these reports, these vaccines have remained widely promoted and, in some cases, required for people of all ages, including young children. For these reasons, I urge regulators to carefully review the licensing process and reconsider the approval status of these vaccines to ensure that public safety and transparency remain the top priorities.